Literature DB >> 8319482

A method for the cryopreservation of liver parenchymal cells for studies of xenobiotics.

B Diener1, D Utesch, N Beer, H Dürk, F Oesch.   

Abstract

An optimized computer-controlled freezing protocol for the cryopreservation of rat liver parenchymal cells was developed. The best survival rates were obtained when a slow cooling rate was used and when the supercooling was interrupted with a shock cooling to initiate ice nucleation. Ten percent dimethyl sulfoxide was added and removed gradually for best results. Thawed rat liver parenchymal cells had a viability, as judged by trypan blue exclusion, of 69% (SD = 6) versus 82% (SD = 7) for freshly isolated cells. The content and activities of the xenobiotic metabolizing enzymes, cytochrome P450, UDP-glucuronosyl transferase, and microsomal and cytosolic epoxide hydrolase, were not affected, whereas a slight reduction of glutathione S-transferase and sulfotransferase occurred. If cryopreserved cells were purified by a Percoll centrifugation after thawing the enzyme activities were not significantly different from those of freshly isolated parenchymal cells and also the viability was 86% (SD = 3). Cryopreserved rat liver parenchymal cells only metabolized about 50% of benzo(a)pyrene compared to freshly isolated cells. It is less likely that the reduction in enzyme activities was due to the cryopreservation procedure than that it was due to the loss of NADPH as a cofactor for cytochrome P450 which then resulted in the decreased xenobiotic metabolism. This cryopreservation protocol was also suitable for a variety of liver parenchymal cells from other species when trypan blue exclusion was used as a viability marker.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8319482     DOI: 10.1006/cryo.1993.1011

Source DB:  PubMed          Journal:  Cryobiology        ISSN: 0011-2240            Impact factor:   2.487


  11 in total

1.  Improved cryopreservation of human hepatocytes using a new xeno free cryoprotectant solution.

Authors:  Mohammed Saliem; Frida Holm; Rosita Bergström Tengzelius; Carl Jorns; Lisa-Mari Nilsson; Bo-Göran Ericzon; Ewa Ellis; Outi Hovatta
Journal:  World J Hepatol       Date:  2012-05-27

2.  A new seed-train expansion method for recombinant mammalian cell lines.

Authors:  Rüdiger Heidemann; Mokhtar Mered; D Q Wang; Bruce Gardner; Chun Zhang; James Michaels; Hans-Jürgen Henzler; Nada Abbas; Konstantin Konstantinov
Journal:  Cytotechnology       Date:  2002-01       Impact factor: 2.058

Review 3.  Hepatocyte cryopreservation: is it time to change the strategy?

Authors:  Xavier Stéphenne; Mustapha Najimi; Etienne M Sokal
Journal:  World J Gastroenterol       Date:  2010-01-07       Impact factor: 5.742

4.  Storage temperatures for cold-chain delivery in cell therapy: a study of alginate-encapsulated liver cell spheroids stored at -80°c or -170°c for up to 1 year.

Authors:  Isobel Massie; Clare Selden; Humphrey Hodgson; Barry Fuller
Journal:  Tissue Eng Part C Methods       Date:  2012-09-07       Impact factor: 3.056

5.  GMP cryopreservation of large volumes of cells for regenerative medicine: active control of the freezing process.

Authors:  Isobel Massie; Clare Selden; Humphrey Hodgson; Barry Fuller; Stephanie Gibbons; G John Morris
Journal:  Tissue Eng Part C Methods       Date:  2014-02-24       Impact factor: 3.056

Review 6.  Hepatocyte transplantation for liver-based metabolic disorders.

Authors:  Anil Dhawan; Ragai R Mitry; Robin D Hughes
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

7.  Barriers to the successful treatment of liver disease by hepatocyte transplantation.

Authors:  Kyle A Soltys; Alejandro Soto-Gutiérrez; Masaki Nagaya; Kevin M Baskin; Melvin Deutsch; Ryotaro Ito; Benjamin L Shneider; Robert Squires; Jerry Vockley; Chandan Guha; Jayanta Roy-Chowdhury; Stephen C Strom; Jeffrey L Platt; Ira J Fox
Journal:  J Hepatol       Date:  2010-06-30       Impact factor: 25.083

8.  Viability, attachment efficiency, and xenobiotic metabolizing enzyme activities are well maintained in EDTA isolated rat liver parenchymal cells after hypothermic preservation for up to 3 days in University of Wisconsin solution.

Authors:  F Oesch; H Abdel-Latif; B Diener
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-09       Impact factor: 2.416

9.  Metabolism of propafenone and verapamil by cryopreserved human, rat, mouse and dog hepatocytes: comparison with metabolism in vivo.

Authors:  B Reder-Hilz; M Ullrich; M Ringel; N Hewitt; D Utesch; F Oesch; J G Hengstler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-03-04       Impact factor: 3.000

Review 10.  Hepatocyte transplantation for metabolic liver disease: UK experience.

Authors:  Robin D Hughes; Ragai R Mitry; Anil Dhawan
Journal:  J R Soc Med       Date:  2005-08       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.